Post

New research · Ophthalmology
Antibiotics (Basel, Switzerland) · 1w
ReviewAntibiotics (Basel, Switzerland) · 2026

Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States.

Inès Fenniri, Camille André
Read paper
OphthalmologyReview

Nearly half of intraocular Staphylococcus aureus in United States surveillance was methicillin-resistant

Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States.

Inès Fenniri, Camille André
Antibiotics (Basel, Switzerland) · 2026
Background

Severe bacterial keratitis and endophthalmitis are leading causes of corneal scarring, enucleation, and permanent vision loss, and are increasingly complicated by multidrug-resistant Gram-positive ocular pathogens.

45.9%
Results
45.9%
Share of eye-infection Staphylococcus aureus samples resistant to methicillin-type antibiotics, 2009-2020
More results

While new antibiotics have been approved for systemic infections, vancomycin remains the standard of care for severe Gram-positive ocular infections.

“
Conclusion

Finally, this review discusses new drugs that represent promising alternatives to vancomycin in ophthalmology.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving